XBIOTECH INC. Convertible Debt, Current
XBIOTECH INC. (XBIT) had Convertible Debt, Current of $10.00 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleDebtCurrent · last filed 2024-11-13
- 2024-09-30: Convertible Debt, Current $10.00M.
- 2024-06-30: Convertible Debt, Current $10.00M.
- 2024-03-31: Convertible Debt, Current $10.00M.
- 2023-12-31: Convertible Debt, Current $0.00.
| Period end | Convertible Debt, Current |
|---|---|
| 2024-09-30 | $10.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $10.00M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $10.00M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |